- Home
- HUM vs CCEP Comparison
HUM vs CCEP Comparison
Compare HUM & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUM | CCEP |
|---|---|---|
| Founded | 1961 | 1986 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.3B | 46.3B |
| IPO Year | 2002 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HUM | CCEP |
|---|---|---|
| Price | $416.72 | $111.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 13 |
| Target Price | ★ $465.13 | $109.31 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 11-06-2026 | 08-04-2026 |
| Dividend Yield | 0.84% | ★ 2.16% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.83 | N/A |
| Revenue | ★ $129,664,000,000.00 | N/A |
| Revenue This Year | $25.51 | $3.48 |
| Revenue Next Year | $3.65 | $3.93 |
| P/E Ratio | $42.73 | ★ $20.93 |
| Revenue Growth | ★ 10.11 | N/A |
| 52 Week Low | $163.11 | $84.66 |
| 52 Week High | $456.50 | $114.55 |
Technical Indicators
Market Signals| Indicator | HUM | CCEP |
|---|---|---|
| Relative Strength Index (RSI) | 53.46 | 61.04 |
| Support Level | $407.50 | $90.22 |
| Resistance Level | $419.36 | $113.67 |
| Average True Range (ATR) | 16.26 | 2.04 |
| MACD | -0.26 | 0.75 |
| Stochastic Oscillator | 49.74 | 80.99 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.